SCHERING-PLOUGH SELECTS COMPOUND FOR FURTHER DEVELOPMENT

Schering-Plough has revealed that it is to further develop a compound for the treatment of respiratory disease identified in the company's collaboration with Pharmacopeia. Under the terms of the collaboration, the selection of the compound triggers a milestone payment to Pharmacopeia.
Pharmaceutical Business Review